Dogus Vuralli
Overview
Explore the profile of Dogus Vuralli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baltu D, Serin O, Aksu T, Hizarcioglu Gulsen H, Orhan D, Yildiz Y, et al.
J Nephrol
. 2024 Jul;
38(1):279-282.
PMID: 39017816
No abstract available.
2.
Kandemir N, Vuralli D, Ozon A, Gonc N, Ardicli D, Jalilova L, et al.
J Diabetes
. 2024 Apr;
16(5):e13562.
PMID: 38664892
Background: Global variations in epidemiology of type 1 diabetes mellitus (T1DM) exist. This study is designed to examine demographic and clinical features of T1DM over the past 3 decades as...
3.
Cayir A, Turkyilmaz A, Rabenstein H, Guven F, Karagoz Y, Vuralli D, et al.
Mol Syndromol
. 2024 Apr;
15(2):104-113.
PMID: 38585545
Introduction: Early-onset severe obesity is usually the result of an underlying genetic disorder, and several genes have recently been shown to cause syndromic and nonsyndromic forms of obesity. The "...
4.
Emet D, Karavar H, Gozmen O, Agyar A, Unsal Y, Canturk M, et al.
J Diabetes
. 2023 Aug;
15(12):1011-1019.
PMID: 37572062
Background: Residual beta-cell function and improvement in insulin sensitivity by reversal of glucose toxicity are two phenomena thought to be related to partial remission (PR). Body fat mass is the...
5.
Vuralli D, Jalilova L, Alikasifoglu A, Ozon Z, Gonc E, Kandemir N
J Clin Res Pediatr Endocrinol
. 2023 Aug;
16(1):11-20.
PMID: 37559367
Objective: Cardiovascular diseases (CVD) are the most important cause of morbidity and mortality in patients with type 1 diabetes (T1D). Children with T1D have a similar or higher prevalence of...
6.
Vuralli D, Ciftci N, Demirbilek H
Clin Endocrinol (Oxf)
. 2023 Mar;
98(6):788-795.
PMID: 36879296
Objective: There is controversial results about serum kisspeptin, neurokinin-B (NKB), anti-Müllerian hormone (AMH) and inhibin B (INHB) levels in girls with central precocious puberty (CPP). Aim of this study is...
7.
Demirbilek H, Vuralli D, Haris B, Hussain K
Diabetes Metab Syndr Obes
. 2023 Feb;
16:259-273.
PMID: 36760580
Hypoglycaemia is common in patients with diabetes mellitus and is a limiting factor for achieving adequate glycaemic control. In the vast majority of cases, hypoglycaemia develops due to the imbalance...
8.
Vuralli D, Yildiz Y, Ozon A, Dursun A, Gonc N, Tokatli A, et al.
J Clin Res Pediatr Endocrinol
. 2022 Mar;
14(3):275-286.
PMID: 35308014
Objective: Phosphomannomutase 2 deficiency (PMM2-CDG) is a disorder of protein N-glycosylation with a wide clinical spectrum. Hypoglycemia is rarely reported in PMM2-CDG. In this study, we evaluated cause, treatment options...
9.
Vuralli D, Gonc N, Ozon A, Ekinci S, Dogan H, Tekgul S, et al.
J Clin Res Pediatr Endocrinol
. 2021 Aug;
14(1):17-28.
PMID: 34380293
Objective: Estrogen-secreting adrenocortical tumors (ACTs) are quite rare with feminizing adrenocortical tumors (FATs) accounting for 0.37-2% of all ACTs. The aim was to evaluate clinical and hormonal characteristics of FATS...
10.
Vuralli D, Gonc E, Alikasifoglu A, Kandemir N, Ozon Z
Arch Endocrinol Metab
. 2021 May;
64(5):591-596.
PMID: 34033300
Objective: The determinants of an increased risk of an organic pathology underlying central precocious puberty (CPP) in girls remain contentious. The present study aimed to determine the clinical and hormonal...